Recurrent hemoptysis in a patient with bronchial asthma
Journal of Advanced Lung Health, 2021 Hemoptysis is not a common symptom in bronchial asthma. We aim to discuss the approach to a patient with uncontrolled asthma with recurrent hemoptysis in this case-based discussion.
Vishnu M Sharma, Baseer Ahmmad Walikar
doaj +1 more source
Allergic bronchopulmonary Aspergillosis in children
TURKISH JOURNAL OF MEDICAL SCIENCES, 2021 Allergic bronchopulmonary aspergillus (ABPA) is a lung disease caused by hypersensitivity from Aspergillus fumigatus. Diagnostic criteria, staging systems and treatment methods for ABPA disease have been reported in studies evaluating populations, the majority of which are adult patients.
Özge ATAY +6 more
openaire +3 more sources
Secondary spontaneous pneumothorax in a patient of allergic bronchopulmonary aspergillosis: an unusual presentation [PDF]
, 2021 Allergic bronchopulmonary aspergillosis (ABPA) is a complex immunologic pulmonary disorder caused by hypersensitivity to fungus, Aspergillus fumigates. It clinically manifests with non-specific respiratory and systemic symptoms. ABPA is typically seen in
Kumar, Surender, Sandal, Shivali
core +2 more sources
Pictorial essay: Allergic bronchopulmonary aspergillosis
Indian Journal of Radiology and Imaging, 2011 Allergic bronchopulmonary aspergillosis (ABPA) is the best-known allergic manifestation of Aspergillus-related hypersensitivity pulmonary disorders. Most patients present with poorly controlled asthma, and the diagnosis can be made on the basis of a ...
Ritesh Agarwal +4 more
doaj +1 more source
Immune responses to airborne fungi and non-invasive airway diseases. [PDF]
, 2014 Inhalation of fungal particles is a ubiquitous way of exposure to microorganisms during human life; however, this exposure may promote or exacerbate respiratory diseases only in particular exposure conditions and human genetic background.
Niculita-Hirzel, Hélène +2 more
core +1 more source
Tezepelumab treatment for allergic bronchopulmonary aspergillosis
Respirology Case Reports, 2023 An 82‐year‐old man had been diagnosed with asthma. He experienced repeated exacerbations requiring treatment with a systemic corticosteroid despite being treated with medications including high‐dose fluticasone furoate/umeclidinium/vilanterol ...
Hiroaki Ogata +8 more
doaj +1 more source
Allergic bronchopulmonary aspergillosis: Indian scenario
Indian Journal of Allergy Asthma and Immunology, 2019 Aspergillus is ubiquitous, occurring in mycelial form and grows at 15-530C and humid conditions. Pulmonary aspergillosis is a clinical spectrum of lung disease caused by the fungus Aspergillus.
Rajendra Prasad +2 more
doaj +1 more source
Immunological corollary of the pulmonary mycobiome in bronchiectasis:The Cameb study [PDF]
, 2018 Understanding the composition and clinical importance of the fungal mycobiome was recently identified as a key topic in a “research priorities” consensus statement for bronchiectasis.
Anusha Matta, Sri +23 more
core +2 more sources
Management of allergic bronchopulmonary aspergillosis: a review and update
Therapeutic Advances in Respiratory Disease, 2012 Since the first description of allergic bronchopulmonary aspergillosis (ABPA) in the 1950s there have been numerous studies that have shed light on the characteristics and immunopathogenesis of this disease.
Mahboobeh Mahdavinia, Leslie C. Grammer
doaj +1 more source
Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells? [PDF]
, 2015 Invasive aspergillosis caused by Aspergillus species (Aspergillus fumigatus, A. flavus and A. terreus) is life-threatening infections in immunocompromised patients.
Agam P. Singh +5 more
core +2 more sources